Ondrugdelivery, a leading name in the pharmaceutical and biotechnology sectors, is headquartered in Great Britain. Founded in 2000, the company has established itself as a pivotal player in drug delivery systems, focusing on innovative solutions that enhance therapeutic efficacy and patient compliance. With a strong presence in Europe and North America, Ondrugdelivery offers a range of services, including drug formulation, delivery device development, and regulatory support. Their unique approach combines cutting-edge technology with extensive industry expertise, setting them apart in a competitive market. Recognised for their commitment to quality and innovation, Ondrugdelivery has achieved significant milestones, including partnerships with major pharmaceutical companies and contributions to groundbreaking research. Their dedication to advancing drug delivery methods continues to solidify their position as a trusted leader in the industry.
How does Ondrugdelivery's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Media Production industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Ondrugdelivery's score of 26 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Ondrugdelivery reported no specific carbon emissions data, as it has not disclosed any Scope 1, Scope 2, or Scope 3 emissions figures. The organisation has not set any reduction targets or climate pledges, indicating a lack of formal commitments to reduce carbon emissions at this time. As a company headquartered in Great Britain, Ondrugdelivery operates within an industry increasingly focused on sustainability and climate action. However, without specific emissions data or reduction initiatives, it remains unclear how the company aligns with broader industry standards for carbon management. The absence of disclosed emissions data suggests that Ondrugdelivery may need to enhance its transparency and commitment to climate action to meet the expectations of stakeholders and regulatory bodies.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ondrugdelivery has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

